TYRA
Tyra Biosciences Inc
NASDAQ: TYRA · HEALTHCARE · BIOTECHNOLOGY
$34.75
+2.86% today
Updated 2026-04-30
Market cap
$2.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$9 – $41
Volume
1.2M
Tyra Biosciences Inc (TYRA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.62M | $-7.76M | $-23.75M | $-50.28M | $-50.14M | $-69.77M | $-95.14M |
| Capital expenditures | $20000.00 | $312000.00 | $661000.00 | $559000.00 | $770000.00 | $664000.00 | $141000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $0.00 | $439000.00 | $2.89M | $10.59M | $13.53M | $22.80M | $28.01M |
| Free cash flow | $-2.64M | $-8.07M | $-24.41M | $-50.84M | $-50.91M | $-70.44M | $-95.28M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $286.96M | $-50.21M | — | — | — |